Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk.

Breast cancer research and treatment - 1 Aug 2021

Strojnik Ksenija, Krajc Mateja, Dragos Vita Setrajcic, Stegel Vida, Novakovic Srdjan, Blatnik Ana

Abstract excerpt

PURPOSE: To analyze the prevalence of pathogenic/likely pathogenic variants (P/LPVs) in BRCA1 and BRCA2 genes in the largest cohort of Slovenian male breast cancer (MBC) patients to date and to explore a possible correlation between the Slovenian founder variant BRCA2:c.7806-2A > G and predisposition to MBC. METHODS: We performed a retrospective analysis of 81 MBC cases who underwent genetic counseling and/or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms, Male

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Slovenia

Source

Open in PubMed Open full text

Identifiers

PMID: 33891299
DOI: 10.1007/s10549-021-06224-5
PMCID: PMC8272709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk.PMID 33891299Read ↗

BRCA2 gene mutations in Slovenian male breast cancer patients.Semantic proximity Read ↗

Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population.Semantic proximity Read ↗

Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.Semantic proximity Read ↗

Germline BRCA testing in routine clinical practice: a single-center experience.Semantic proximity Read ↗

BRCA2 mutations in 154 finnish male breast cancer patients.Semantic proximity Read ↗

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.Semantic proximity Read ↗

Identification of BRCA1 and BRCA2 Germline Mutations in Female Breast Cancer Patients Using Next Generation Sequencing.Semantic proximity Read ↗

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan.Semantic proximity Read ↗

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.Semantic proximity Read ↗

Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer.Semantic proximity Read ↗

Prevalence of recurrent and non-recurrent BRCA1 and BRCA2 pathogenic variants in Polish breast cancer patients: insights from a regional genetic testing cohort from Lower Silesia.Semantic proximity Read ↗

Male Breast Cancer: From Molecular Genetics to Clinical ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.